The MMRF Blog - Multiple Myeloma Research Foundation

The MMRF Blog

Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02.

Leleu X, Karlin L, Macro M, Hulin C, Garderet L, Roussel M, Arnulf B, Pegourie B, Kolb B, Stoppa AM, Brechiniac S, Marit G, Thielemans B, Onraed B, Mathiot C, Banos A, Lacotte L, Tiab M, Dib M, Fuzibet JG, Petillon MO, Rodon P, Wetterwald M, Royer B, Legros L, Benboubker L, Decaux O, Escoffre-Barbe M, Caillot D, Fermand JP, Moreau P, Attal M, Avet-Loiseau H, Facon T. READ MORE

Posted: January 22, 2015

MMRF Multiple Myeloma Patient Survey

We strive to keep our community up-to-date on new treatments and clinical trials, important events, and our progress in advancing a cure for multiple myeloma. We want to hear about your journey with myeloma- so we have commissioned a survey so we can learn more from you. READ MORE

Posted: January 20, 2015

34 Clinical Profile of Single-Agent Oprozomib in Patients (Pts) with Multiple Myeloma (MM): Updated Resultss from a Multicenter, Open-Label, Dose Escalation Phase 1b/2 Study

Ravi Vij, MBBS, MD1, Michael Savona, MD2, David S. Siegel, MD, PhD3, Jonathan L. Kaufman, MD4, Ashraf Badros, MD5, Irene M. Ghobrial, MD6, Agne Paner, MD7, Sundar Jagannath, MD8, Andrzej Jakubowiak, MD, PhD9, Joseph R. Mikhael, MD10, Prashant Kapoor, MD11, Linda L. Neuman, MD, MBA12, Ju RueyJiuan Lee, PhD13* and Jesus G. Berdeja, MD14 READ MORE

Posted: January 16, 2015

Page 80 of 87« First...102030...7879808182...Last »